SENSEX NIFTY

Vaccine

Aug 24, 2016 at 14:33 | Source: CNBC-TV18
In earnings' conference call, Jhunjhunwala who currently holds 1.12 percent stake in the company threw a volley of questions to the management. The big bull raised questions on Aurobindo Pharma's finance cost, capex, rationale behind investment in vaccines, product launch, potential revenue growth and its fund raising plans.
Aug 23, 2016 at 19:40 | Source: PTI
Chennai-based GreenSignal Bio Pharma is likely to come out with an Initial Public Offer (IPO) in October to raise around Rs 100 crore.
Aug 15, 2016 at 17:30 | Source: PTI
Vaccines segment is another addition to the company's differentiated portfolio where there are unmet needs and limited competition, Aurobindo Pharma said in its annual report.
Jul 29, 2016 at 15:10 | Source: CNBC-TV18
Twenty three percent revenue run rate is sustainable for the full year, said Rajiv Gandhi, CEO & MD of Hester Biosciences.
Jun 24, 2016 at 06:44 | Source: PTI
Nadda was speaking after reviewing the special immunisation drive undertaken in Hyderabad and Ranga Reddy districts in the wake of VDPV being found here, with state Health Minister C Laxma Reddy and officials.
Jun 15, 2016 at 22:08 | Source: PTI
"The campaign, to be conducted from June 20 to 26, would be carried out at 700 booths," said Lalitha Kumari, Director of Public Health and Family Welfare.
Jun 15, 2016 at 17:00 | Source: PTI
Amidst concerns over wild polio virus (P2 strain) being found in a Hyderabad drain, the Union Health Ministry said it was a vaccine derived virus and does not change the polio-free status of India
May 25, 2016 at 21:22 | Source: PTI
Biotechnology major Biocon has proposed an investment of Rs 1,060 crore for the manufacture of injectables, monoclonal and anti-bodies vaccine at Anekal taluk. It is expected to employ about 750 people, an official release said.
Mar 22, 2016 at 17:51 | Source: CNBC-TV18
The World Health Organization (WHO) has issued a Notice of Concern to Cadila Healthcare over a unit in its Moraiya plant that manufactures vaccines.
Feb 16, 2016 at 08:58 | Source: Reuters
To make a new drug in India, companies need permission from the national drug controller after submitting safety and efficacy data including from local clinical trials. For four years after an approved drug is on the market, firms must submit safety reports, including those on adverse drug reactions.
Messages on Vaccine »

BSE/NSE Announcer

Platinum Member

16500 Followers

Hester Bio  

Hester Biosciences received the WHO GMP Certification for Poultry Vaccine. This certification would help Hester in hastening the registration process in many countries, as well as in opening the registration doors in the regulated markets.

11.38 AM Feb 9th 2013

BSE/NSE Announcer

Platinum Member

16500 Followers

Hester Bio  

Hester Biosciences Ltd has informed BSE regarding a Press Release dated February 08, 2013, titled "WHO GMP Certification awarded to Hester Launching of Bivalent Mareks Disease Live Vaccine containing HVT & SB1 Strains"

11.13 AM Feb 9th 2013

Cheek

Silver Member

0 Follower

Panacea Biotec  

Net sales of the company rose to Rs 166.28 crore for the quarter under consideration from Rs 152.98 crore for the same period year ago, Panacea Biotec said in a filing to the BSE. “The company has got orders from the Government of India for supply of Trivalent Oral Polio Vaccines and Bivalent Oral

10.30 PM Feb 8th 2013

Wire News

Platinum Member

609 Followers

News Now  

TB-VACCINE:Key TB vaccine trial fails; more waiting in the wings

5.46 PM Feb 4th 2013

Web Messenger

Platinum Member

362318 Followers

GlaxoSmithKline  

Source:DNA India - GlaxoSmithKline (GSK), the British drug major, is the latest multinational to ink a deal with an Indian pharma firm. It has formed an equal-stake joint venture with Hyderabad-based Biological E for research and development (R D) activities pertaining to a six-in-one kids vaccine

7.24 PM Jan 29th 2013

Web Messenger

Platinum Member

362318 Followers

GlaxoSmithKline  

Source:The Hindu BusinessLine - Mumbai, Jan 28: Multinational drug-maker GlaxoSmithKline and Biological E Ltd, an Indian vaccines company, have announced an agreement to form an equally-partnered joint venture for early stage research and development of a six-in-one combination paediatric vaccine

4.06 PM Jan 29th 2013

GlaxoSmithKline  

GSK, Biological E tie up on combination vaccine targeting infectious diseases including polio.

3.31 PM Jan 28th 2013

Web Messenger

Platinum Member

362318 Followers

GlaxoSmithKline  

Source:Business Standard - Billionaire Cyrus Poonawalla, founder of the world s biggest maker of vaccines, will slash the price of polio immunisation and introduce shots for diarrhea and pneumonia, undercutting Pfizer and GlaxoSmithKline ( GSK). Poonawalla, who set up the Serum Institute of India

2.37 PM Jan 23rd 2013

Web Messenger

Platinum Member

362318 Followers

Essar Oil  

Source:The Hindu BusinessLine - Essar Foundation, on Tuesday, said it will provide medical aid to over 10,000 cattle through cattle vaccination camps and public awareness programs in 10 surrounding villages of the Vadinar refinery in Jamnagar district of Gujarat.Recently, Essar Foundation

2.28 PM Dec 26th 2012

sreelupavan

Platinum Member

21 Followers

Politics  

At least he will be better leader than existing worst leaders we have at present. we badly needed new vaccinated blood in the indian politics

4.28 PM Dec 20th 2012

News across the web »
Mar 22, 2016 at 22:33 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.